Peripheral Vascular Disease
Thrombophlebitis
Raynaud’s Syndrome Early Studies by Miley listed the treatments of disorders caused by vascular blockage in the legs and arms . In some cases avoiding amputation of gangrenous toes and feet, reversing hopeless swelling and cyanosis.
Thromboangiitis obliterans
2 UBI treatments, two gangrenous toes were removed. Patient convalesced and was able to return to work. He was undergoing treatment with UBI on a quarterly basis. Upon stopping treatment Buerger’s disease appeared again. 2 UBI treatments given again and the pain disappeared.
Miley, G.P., Olney, R.C., Lewis, H.T. (1997). Ultraviolet Blood Irradiation: A History and Guide to Clinical Application 1933-1997). Silver Spring, Maryland: Foundation for Blood Irradiation.
Thrombophlebitis
13 cases treated at the Clinic of Hahnemann Medical College and Hospital in Philadelphia. 5 cases were first tried with drugs and treatment had failed. UBI treatments were administered and first pain disappeared, then fever, finally edema.
Miley, G. P. (1943). "The Control of Acute Thrombophlebitis with Ultraviolet Blood Irradiation Therapy," American Journal of Surgery 60:3:354-60
Double Blind Study of 50 patients in Fontaine Stage II of arterial disease.
Group 1 - 16 weeks of drug therapy distance walking improved 160%
Group 2 – 4-6 weeks inpatient therapy increased 100%
Group 3 – 6 day placebo with UBI (no light) 90% improvement
Group 4 – 6 day real UBI treatment - 360% improvement
Results confirmed in 18 subsequent trials and reports. Smoking and diabetes patients were more difficult and required more UBI treatments.
Frick, G. (1989). Fibel der Ultrviolettbestrahlung des Blutes. Ernst-Moritz-Arndt-Universitaet Greifswald
Results are markedly superior to a standard drug regime. Drugs for intermittent claudication like pentoxifylline (Trental) only show a 19-65% increase in walking distance.
Young, Jess R., Olin, Jeffery W. and Bartholomew, John R., Peripheral Vascular Diseases, 2nd edition, St Louis, Mosby, 1996, pp 377-8
Raynaud’s Syndrome
28 patients received LBI with 30 patients as controls receiving standard treatment
LBI Standard Drug Therapy
43% significant improvement 33% significant improvement
50 % benefited 16.7% benefited
7% no response 50% no response
1 worsened
Izhevsk, “Use of Low-Intensity lasers in Experimental and clinical Medicine [Russian] (1994) pp 63-64
Raynaud’s Syndrome Early Studies by Miley listed the treatments of disorders caused by vascular blockage in the legs and arms . In some cases avoiding amputation of gangrenous toes and feet, reversing hopeless swelling and cyanosis.
Thromboangiitis obliterans
2 UBI treatments, two gangrenous toes were removed. Patient convalesced and was able to return to work. He was undergoing treatment with UBI on a quarterly basis. Upon stopping treatment Buerger’s disease appeared again. 2 UBI treatments given again and the pain disappeared.
Miley, G.P., Olney, R.C., Lewis, H.T. (1997). Ultraviolet Blood Irradiation: A History and Guide to Clinical Application 1933-1997). Silver Spring, Maryland: Foundation for Blood Irradiation.
Thrombophlebitis
13 cases treated at the Clinic of Hahnemann Medical College and Hospital in Philadelphia. 5 cases were first tried with drugs and treatment had failed. UBI treatments were administered and first pain disappeared, then fever, finally edema.
Miley, G. P. (1943). "The Control of Acute Thrombophlebitis with Ultraviolet Blood Irradiation Therapy," American Journal of Surgery 60:3:354-60
Double Blind Study of 50 patients in Fontaine Stage II of arterial disease.
Group 1 - 16 weeks of drug therapy distance walking improved 160%
Group 2 – 4-6 weeks inpatient therapy increased 100%
Group 3 – 6 day placebo with UBI (no light) 90% improvement
Group 4 – 6 day real UBI treatment - 360% improvement
Results confirmed in 18 subsequent trials and reports. Smoking and diabetes patients were more difficult and required more UBI treatments.
Frick, G. (1989). Fibel der Ultrviolettbestrahlung des Blutes. Ernst-Moritz-Arndt-Universitaet Greifswald
Results are markedly superior to a standard drug regime. Drugs for intermittent claudication like pentoxifylline (Trental) only show a 19-65% increase in walking distance.
Young, Jess R., Olin, Jeffery W. and Bartholomew, John R., Peripheral Vascular Diseases, 2nd edition, St Louis, Mosby, 1996, pp 377-8
Raynaud’s Syndrome
28 patients received LBI with 30 patients as controls receiving standard treatment
LBI Standard Drug Therapy
43% significant improvement 33% significant improvement
50 % benefited 16.7% benefited
7% no response 50% no response
1 worsened
Izhevsk, “Use of Low-Intensity lasers in Experimental and clinical Medicine [Russian] (1994) pp 63-64